# Long-Acting Growth Hormone in Children Compared to Daily rhGH

> **NCT02339090** · PHASE3 · COMPLETED · sponsor: **Versartis Inc.** · enrollment: 138 (actual)

## Conditions studied

- Growth Disorders

## Interventions

- **DRUG:** Somavaratan
- **DRUG:** rhGH

## Key facts

- **NCT ID:** NCT02339090
- **Lead sponsor:** Versartis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-26
- **Primary completion:** 2017-08-23
- **Final completion:** 2017-08-23
- **Target enrollment:** 138 (ACTUAL)
- **Last updated:** 2022-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02339090

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02339090, "Long-Acting Growth Hormone in Children Compared to Daily rhGH". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02339090. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*